Trademark Overview
On Monday, March 31, 2025, a trademark application was filed for VEILTX with the United States Patent and Trademark Office. The USPTO has given the VEILTX trademark a serial number of 99112929. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 31, 2025. This trademark is owned by Veil Therapeutics, Inc.. The VEILTX trademark is filed in the Pharmaceutical Products category with the following description:
biochemical and biological substances for medical diagnostics and analysis, namely, detection of anti-PEG antibodies, anti-POEGMA antibodies, other immunogenic responses that hinder a therapeutic intervention, and companion diagnostics; pharmaceutical and veterinary preparations for medical purposes, including contrast agents and contrast media used in medical imaging such as contrast media used for X-ray, MRI, or ultrasound imaging; Therapeutic peptides, proteins, small molecules, antibodies, polypeptides, drug-conjugates, lipid nanoparticles, aptamers, liposomes, microparticles, micelles, and polymers for the purpose of providing therapeutic intervention with altered pharmacokinetics and reduced immunogenicity; pharmaceutical preparations and substances for the treatment of gout, solid and liquid tumors, autoimmune disease, metabolic disorders, cardiovascular disease, infectious disease, and other disorders and diseases treatable with enzyme replacement therapy
